Human Papillomavirus Molecular Detection with Genotyping
Human papillomavirus (HPV) infection is a significant cause of morbidity and mortality worldwide and screening for this virus in the appropriate patients can have a dramatic impact on reducing death related to HPV-associated cervical cancer. The recommended cervical cancer screening guidelines outline what testing should be done and when this testing should be performed and suggest that early detection of HPV-16 and HPV-18 may prevent the progression of cervical cancer. Dr. Binnicker explains the appropriate use of new molecular testing for detection of HPV with reflex to genotyping for HPV-16 and 18.
- Matthew Binnicker, PhD
- Director of the Clinical Virology Laboratory in the Division of Clinical Microbiology at Mayo Clinic in Rochester, Minnesota.
Related Hot Topics
- Cervical Cytology and HPV Testing: What's New and What You Need to Know
- HPV and p16 Testing in Oropharyngeal Squamous Cell Carcinoma: Methodology, Interpretation, and Significance
- HPV / Human Papillomavirus (HPV) DNA Detection with Genotyping, High-Risk Types by PCR, ThinPrep
- SHPV / Human Papillomavirus (HPV) DNA Detection with Genotyping, High-Risk Types by PCR, SurePath
Forward to a Colleague
Share this presentation with:
- Obstetricians and Gynecologists
- Infectious Disease Physicians
If you have questions, e-mail .